Advertisement
Advertisement
IFRX
InflaRx N.V. Common Stock
0.89
USDSponsored
-0.03
-3.76%
Jan 30, 15:59 UTC -5
Closed
After-Market
0.90
+0.01
+0.79%
IFRX Earnings Reports
Positive Surprise Ratio
IFRX beat 20 of 33 last estimates.
61%
Next Report
Date of Next Report
Mar 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$118.02K
/-$0.15
Implied change from Q3 25 (Revenue/ EPS)
+391.77%
/-16.67%
Implied change from Q4 24 (Revenue/ EPS)
-11902.40%
/+87.50%
InflaRx N.V. Common Stock earnings per share and revenue
On Nov 10, 2025, IFRX reported earnings of -0.18 USD per share (EPS) for Q3 25, missing the estimate of -0.15 USD, resulting in a -16.50% surprise. Revenue reached 24.00 thousand, compared to an expected 73.78 thousand, with a -67.47% difference. The market reacted with a +28.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 118.02 thousand USD, implying an decrease of -16.67% EPS, and increase of 391.77% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
What were InflaRx N.V. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, InflaRx N.V. Common Stock reported EPS of -$0.18, missing estimates by -16.5%, and revenue of $24.00K, -67.47% below expectations.
How did the market react to InflaRx N.V. Common Stock's Q3 2025 earnings?
The stock price moved up 28.46%, changed from $1.23 before the earnings release to $1.58 the day after.
When is InflaRx N.V. Common Stock expected to report next?
The next earning report is scheduled for Mar 18, 2026.
What are the forecasts for InflaRx N.V. Common Stock's next earnings report?
Based on 9
analysts, InflaRx N.V. Common Stock is expected to report EPS of -$0.15 and revenue of $118.02K for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement